Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

A combination chemotherapy of irinotecan (CPT-11) and cisplatin (CDDP) has been reported to be active for lung cancer. In the previous trial, however, diarrhoea and leucopenia became the major obstacle for sufficient dose escalation of CPT-11 to improve the treatment outcome. We conducted a phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueoka, H, Tabata, M, Kiura, K, Shibayama, T, Gemba, K, Segawa, Y, Chikamori, K, Yonei, T, Hiraki, S, Harada, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362688/
https://www.ncbi.nlm.nih.gov/pubmed/10070901
http://dx.doi.org/10.1038/sj.bjc.6690157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362688/
https://www.ncbi.nlm.nih.gov/pubmed/10070901
http://dx.doi.org/10.1038/sj.bjc.6690157

Ejemplares similares